ANEURYSMAL DILATATION OF DUCTUS-ARTERIOSUS DURING LIPO-PROSTAGLANDIN-E(1) THERAPY FOR DIAPHRAGMATIC-HERNIA

被引:4
|
作者
TOHYAMA, M
BABA, A
TSUNO, T
AONUMA, K
KOMIYAMA, A
机构
[1] Department of Paediatrics, Shinshu University, Matsumoto, 390
关键词
PATENT DUCTUS ARTERIOSUS; PERSISTENT FETAL CIRCULATION; LIPO-PGE(1); CONGENITAL DIAPHRAGMATIC HERNIA;
D O I
10.1007/BF01957520
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We report a case of congenital diaphragmatic hernia in which aneurysmal dilatation of ductus arteriosus developed after lipo-prostaglandin E1 (PGE1) therapy for persistent fetal circulation. After surgery Lipo-PGE1 was used at a dosage of 5 ng/kg per minute from days 2-9 during which aneurysmal dilatation (7 mm in diameter) developed and remained thereafter. Ductus arteriosus ligation was then performed. Lipo-PGE1 may promote ductus arteriosus dilatation in cases of persistent fetal circulation.
引用
收藏
页码:877 / 879
页数:3
相关论文
共 27 条
  • [11] HISTOPATHOLOGY OF THE ARTERIAL DUCT (DUCTUS-ARTERIOSUS) WITH AND WITHOUT TREATMENT WITH PROSTAGLANDIN-E1
    GITTENBERGERDEGROOT, AC
    STRENGERS, JLM
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1988, 19 (02) : 153 - 166
  • [12] PROLONGED PROSTAGLANDIN-E1 INFUSION - HISTOLOGIC EFFECTS ON THE PATENT DUCTUS-ARTERIOSUS
    COLE, RB
    ABMAN, S
    AZIZ, KU
    BHARATI, S
    LEV, M
    PEDIATRICS, 1981, 67 (06) : 816 - 819
  • [13] DUCTUS-ARTERIOSUS RESPONSES TO PROSTAGLANDIN-E1 AT HIGH AND LOW OXYGEN CONCENTRATIONS
    CLYMAN, RI
    HEYMANN, MA
    RUDOLPH, AM
    PROSTAGLANDINS, 1977, 13 (02): : 219 - 223
  • [14] ANEURYSMAL CHANGE OF THE DUCTUS-ARTERIOSUS AFTER PROSTAGLANDIN-E1 ADMINISTRATION FOR PULMONARY ATRESIA - DEMONSTRATION WITH MAGNETIC-RESONANCE-IMAGING
    TSUBATA, S
    HASHIMOTO, I
    ICHIDA, F
    MIYAZAKI, A
    OKADA, T
    MURAKAMI, A
    MORITA, H
    FUKAHARA, K
    PEDIATRIC CARDIOLOGY, 1994, 15 (01) : 30 - 32
  • [15] EFFICIENCY OF PROSTAGLANDIN-E1 IN A TINY BABY WITH COARCTATION OF THE AORTA AND LIGATED DUCTUS-ARTERIOSUS
    HASCOET, JM
    DIDIER, F
    MONIN, P
    VERT, P
    ACTA PAEDIATRICA, 1992, 81 (11) : 938 - 940
  • [16] THE MORPHOLOGY OF THE HUMAN NEWBORN DUCTUS-ARTERIOSUS - A REAPPRAISAL OF ITS STRUCTURE AND CLOSURE WITH SPECIAL REFERENCE TO PROSTAGLANDIN-E1 THERAPY
    SILVER, MM
    FREEDOM, RM
    SILVER, MD
    OLLEY, PM
    HUMAN PATHOLOGY, 1981, 12 (12) : 1123 - 1136
  • [17] PROSTAGLANDIN-E1 IN THE TREATMENT OF NEONATAL CARDIAC DISEASE WITH PERSISTENT DUCTUS-ARTERIOSUS - 19 CASES
    MAESEN, Y
    BOSI, G
    STIJNS, M
    VLIERS, A
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1981, 74 (05): : 579 - 585
  • [18] FAILURE OF CLINICAL-RESPONSE TO PROSTAGLANDIN-E1 IN A CYANOTIC INFANT WITH CONGENITAL ABSENCE OF THE DUCTUS-ARTERIOSUS
    HAMILTON, WT
    LACINA, SJ
    BHARATI, S
    LEV, M
    ARCILLA, RA
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1982, 8 (03): : 273 - 276
  • [19] PROLONGED USE OF PROSTAGLANDIN-E1 TO MAINTAIN PATENCY OF DUCTUS-ARTERIOSUS IN CONGENITAL HEART-DISEASE
    IVEY, HH
    WELLS, HH
    KATTWINKEL, J
    TOMPKINS, DG
    HUBBELL, MM
    PEDIATRIC RESEARCH, 1978, 12 (04) : 384 - 384
  • [20] DILATION OF THE DUCTUS-ARTERIOSUS BY ORAL PROSTAGLANDIN-E(1) DERIVATIVE IN CYANOTIC CONGENITAL HEART-DISEASES
    MATSUURA, H
    SAJI, T
    YAMAMOTO, S
    ISHIKITA, T
    AOKI, Y
    MATSUO, N
    AMERICAN HEART JOURNAL, 1993, 125 (05) : 1453 - 1454